Optimization of tocol emulsions for the intravenous delivery of clarithromycin

作者: Jie Li , Shufang Nie , Xingang Yang , Changguang Wang , Shuxia Cui

DOI: 10.1016/J.IJPHARM.2007.12.046

关键词: ChromatographyPoloxamerZeta potentialAntibacterial agentBox–Behnken designClarithromycinIrritationOleic acidEmulsionStereochemistryChemistry

摘要: In the present study, novel less-painful tocol emulsions for intravenous delivery of clarithromycin were prepared and optimized. The therapeutically effective concentration clarithromycin, 5mg/ml, was achieved using tocopherol succinate (TS) combined with oleic acid as lipophilic counterions. possibility employing microdialysis technique to investigate distribution drug in explored. A three-level three-factorial Box-Behnken experimental design utilized conduct experiments. effects selected variables, succinate/oleic relation, poloxamer 188 content 0.1M NaOH amount, on three considered responses investigated. particle size, zeta potential oil phase optimized formulation observed be 138.5 nm, -32.16 mV 97.28%, respectively. formula demonstrated good physical stability during storage at 4 degrees C room temperature. histopathological examination rabbit ear vein irritation test indicated that could eliminated by formulating a emulsion.

参考文章(30)
Youmin Wang, Gebre‐Mariam Mesfin, Carlos A. Rodríguez, John G. Slatter, Margaret R. Schuette, Andrea L. Cory, Michael J. Higgins, Venous irritation, pharmacokinetics, and tissue distribution of tirilazad in rats following intravenous administration of a novel supersaturated submicron lipid emulsion Pharmaceutical Research. ,vol. 16, pp. 930- 938 ,(1999) , 10.1023/A:1018846607804
G. E. P. Box, D. W. Behnken, Some New Three Level Designs for the Study of Quantitative Variables Technometrics. ,vol. 2, pp. 455- 475 ,(1960) , 10.1080/00401706.1960.10489912
Chandra S. Chaurasia, Markus Müller, Edward D. Bashaw, Eva Benfeldt, Jan Bolinder, Ross Bullock, Peter M. Bungay, Elizabeth C. M. DeLange, Hartmut Derendorf, William F. Elmquist, Margareta Hammarlund-Udenaes, Christian Joukhadar, Dean L. Kellogg, Craig E. Lunte, Carl Henrik Nordstrom, Hans Rollema, Ronald J. Sawchuk, Belinda W. Y. Cheung, Vinod P. Shah, Lars Stahle, Urban Ungerstedt, Devin F. Welty, Helen Yeo, AAPS‐FDA Workshop White Paper: Microdialysis Principles, Application, and Regulatory Perspectives Pharmaceutical Research. ,vol. 24, pp. 1014- 1025 ,(2007) , 10.1177/0091270006299091
Keith A. Rodvold, Clinical pharmacokinetics of clarithromycin. Clinical Pharmacokinectics. ,vol. 37, pp. 385- 398 ,(1999) , 10.2165/00003088-199937050-00003
M.W. Lovell, H.W. Johnson, H.-W. Hui, J.B. Cannon, P.K. Gupta, C.C. Hsu, Less-painful emulsion formulations for intravenous administration of clarithromycin International Journal of Pharmaceutics. ,vol. 109, pp. 45- 57 ,(1994) , 10.1016/0378-5173(94)90120-1
Muhannad Jumaa, Bernd W Müller, Parenteral emulsions stabilized with a mixture of phospholipids and PEG-660-12-hydroxy-stearate: evaluation of accelerated and long-term stability European Journal of Pharmaceutics and Biopharmaceutics. ,vol. 54, pp. 207- 212 ,(2002) , 10.1016/S0939-6411(02)00057-7
Panayiotis P Constantinides, Alex Tustian, Dean R Kessler, Tocol emulsions for drug solubilization and parenteral delivery Advanced Drug Delivery Reviews. ,vol. 56, pp. 1243- 1255 ,(2004) , 10.1016/J.ADDR.2003.12.005
Nele Plock, Charlotte Kloft, Microdialysis--theoretical background and recent implementation in applied life-sciences. European Journal of Pharmaceutical Sciences. ,vol. 25, pp. 1- 24 ,(2005) , 10.1016/J.EJPS.2005.01.017
Christian Höcht, Javier A.W. Opezzo, Carlos A. Taira, Applicability of reverse microdialysis in pharmacological and toxicological studies. Journal of Pharmacological and Toxicological Methods. ,vol. 55, pp. 3- 15 ,(2007) , 10.1016/J.VASCN.2006.02.007